Results 171 to 180 of about 6,488 (253)

A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent‐Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6584-6594, August 2026.
ABSTRACT Introduction Type 1 diabetes (T1D) is a chronic autoimmune disease, characterised by progressive destruction of the insulin‐producing pancreatic β‐cells. Preserving remaining β‐cells at the time of diagnosis may improve long‐term outcomes. Frexalimab is a humanised monoclonal antibody specific for CD40L undergoing evaluation for treatment of ...
Andriy Cherkas, Baerbel Rotthaeuser, Niels Porksen, Pascale Labard, My‐Liên Nguyên‐Pascal, Mathieu Coudert, Baptiste Berthou, Marie Baccara‐Dinet, Gabor Boka, Mark Peakman, Felix Reschke, Michael J. Haller   +11 more
wiley   +1 more source

CXCL12 and eotaxin are independent prognostic serum biomarkers in gastric cancer. [PDF]

Sci Rep
Brodkin J, Kaprio T, Mustonen H, Leppä A, Kokkola A, Salmi M, Jalkanen S, Haglund C, Böckelman C.   +8 more
europepmc   +1 more source

Impact of Time of Injection on the Efficacy and Safety of iGlarLixi Versus IDegAsp in Chinese People With Type 2 Diabetes: Exploratory Analysis of the Soli‐D Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 6965-6972, August 2026.
ABSTRACT Aims To compare the efficacy and safety of the fixed‐ratio combination of insulin glargine 100 U/mL plus lixisenatide (iGlarLixi) with premixed insulin degludec plus insulin aspart (IDegAsp) according to the injection time of IDegAsp. Materials and Methods The 24‐week, multicentre, randomised, open‐label Soli‐D study enrolled Chinese adults ...
Xin Li, Juan Wang, Tong Liu, Agustina Alvarez, Felipe Lauand, Lydie Melas‐Melt, Lei Kang, Qin Du, Ming Liu   +8 more
wiley   +1 more source

Performance emission and combustion characteristics of TIO₂ and CEO₂ nanoparticle enhanced Mahua biodiesel diesel blends using experimental and machine learning approaches. [PDF]

Sci Rep
Janaki V, Ranjit PS, Balakrishna B.
europepmc   +1 more source

Differential diffusion modelling for LES of premixed and partially premixed flames with presumed FDF

Combustion Theory and Modelling
Gioele Ferrante, Georg Eitelberg, Ivan Langella   +2 more
openaire   +1 more source

Pretreatment With BTK Inhibitors Improved the Sensitivity of DLBCL Cells to CAR‐T Cells in a Coculture System by Downregulating the Polarisation of M2 Macrophages

Journal of Cellular and Molecular Medicine, Volume 30, Issue 15, August 2026.
ABSTRACT The tumour microenvironment (TME) of relapsed/refractory (R/R) diffuse large B‐cell lymphoma (DLBCL) patients is associated with resistance of DLBCL cells to CD19 CAR‐T cells. How to improve TME in DLBCL and improve the efficacy of CAR‐T cell therapy remains to be further explored.
Yao Qi, Xuemei Fan, Jia Wang, Xin Li, Juan Mu, Rui Cui, Qi Deng   +6 more
wiley   +1 more source

A Micro-Computed Tomography Analysis of Void Formation in Apical Plugs Created with Calcium Silicate-Based Materials Using Various Application Techniques in 3D-Printed Simulated Immature Teeth. [PDF]

Dent J (Basel)
Hristov K, Bogovska-Gigova R.
europepmc   +1 more source

NOx reduction in partially premixed combustion

, 2002
openaire   +2 more sources

Pre‐anaesthetic risk assessment and management of dogs with myxomatous mitral valve disease: a spectrum of care narrative review

Journal of Small Animal Practice, Volume 67, Issue 8, Page 663-679, August 2026.
Myxomatous mitral valve disease, an acquired valvular degeneration, is the most common cardiac disorder in dogs, affecting approximately 10% of dogs in primary care veterinary practice. Dogs with myxomatous mitral valve disease frequently require anaesthesia for routine procedures.
I. Levinzon, L. Köster, E. Vettorato, A. H. Estrada   +3 more
wiley   +1 more source

Experimental Study of Flame Dynamics in a Triple-Injector Swirling Nonpremixed Combustor Under Different Thermoacoustic Self-Excited Instability Modes. [PDF]

Sensors (Basel)
Zhang X, Wang S, Liu Y.
europepmc   +1 more source